|
Reasons why oncology experience with rituximab is most helpful |
| Non-Hodgkin's lymphoma and autoimmune diseases have similarities |
| Provides information on chronic use |
| Provides a large safety database of >370,000 patient exposures |
| Provides 7 years of postmarketing experience |
| Extensive experience allows us to predict and manage infusion reactions |
| Low infection rate in oncology provides information on potential for infection in rheumatoid arthritis |
Mohrbacher Arthritis Research & Therapy 2005 7(Suppl 3):S19 doi:10.1186/ar1739 |